De.mem Targets Record CY2026 Results after 1H Cash Flow Turnaround

De.mem posts improved cash flow and growth, but full-year targets lack supporting detail.

What the company is saying

De.mem Limited frames its first-half update around headline growth metrics, reporting $20 million in cash receipts and positive operating cash flow of $928,000. The company emphasizes a turnaround from a $1.9 million outflow in CY2022 and highlights a cash increase to $4.3 million at 30 June 2026. Management stresses the recurring nature of revenue, with over 90% of receipts from repeat sources, and projects confidence by targeting record results for CY2026. The narrative leans on the acquisition of Core Chemicals, citing its $4 million pre-acquisition revenue and 15% post-acquisition growth, and references a compound annual growth rate of 24% over seven years. De.mem also points to its addressable market size of $2.3 billion and a streak of 29 quarters of growth, though without granular data. The tone is upbeat and forward-looking, but omits net profit, EBITDA, or detailed breakdowns that would substantiate the full-year outlook.

What the data suggests

The disclosed numbers show a clear improvement in operating cash flow, moving from a $1.9 million outflow in CY2022 to a $928,000 inflow in the first half. Cash receipts of $20 million for the half suggest the company is on track to match or exceed the $32.2 million achieved in CY2025, assuming typical second-half weighting. Cash on hand increased modestly from $4 million to $4.3 million, indicating positive but limited liquidity growth. The acquisition of Core Chemicals adds about $4 million in revenue and $730,000 in pre-tax profit, with a reported 15% revenue uplift post-acquisition. Over 90% recurring revenue points to a stable customer base. However, the absence of net profit, EBITDA, or segment data limits assessment of underlying profitability and sustainability. The claim of 29 consecutive quarters of growth cannot be independently verified from the data provided, and the $2.3 billion market size is aspirational rather than realised.

Analysis

The announcement is upbeat, highlighting improved cash flow, recurring revenue, and acquisition-driven growth. However, the narrative leans on forward-looking statements such as 'targeting record results for CY2026' and references to addressable market size, which are not substantiated by current, realised financials. While the company discloses positive operating cash flow and cash receipts, there is no mention of net profit, EBITDA, or other profitability metrics, limiting the ability to assess the sustainability or quality of growth. The acquisition of Core Chemicals is a significant capital outlay, but the benefits are only partially realised and future growth is implied rather than demonstrated. The claim of 29 consecutive quarters of growth is not supported by detailed data. Overall, the language is somewhat inflated relative to the evidence, with a gap between the company's optimistic tone and the measurable progress disclosed.

Risk flags

• ●The absence of net profit, EBITDA, or detailed segment disclosures prevents a full assessment of profitability and underlying business health. This matters because cash flow improvements may not translate to sustainable earnings or shareholder returns.
• ●Forward-looking claims, such as targeting record results for CY2026 and referencing a $2.3 billion addressable market, are not supported by binding contracts or detailed forecasts. This raises the risk that actual results may fall short of management’s aspirations.
• ●The claim of 29 consecutive quarters of cash receipts growth is not substantiated by quarter-by-quarter data, making it impossible to verify the consistency or quality of growth. Unsupported streaks can overstate operational momentum.
• ●Acquisition-driven growth, including the $2.68 million Core Chemicals purchase, introduces integration and execution risk. While post-acquisition revenue is up 15%, there is no detail on cost structure, margin impact, or how sustainable this uplift will be.

Bottom line

De.mem Limited’s update signals improving cash flow and recurring revenue, with acquisition-driven growth contributing to a positive first-half result. The company’s upbeat narrative and record CY2026 target are only partially substantiated by disclosed numbers, as key profitability metrics and detailed forecasts are missing. The heavy reliance on headline growth rates, addressable market size, and unverified streaks introduces a moderate hype element and leaves open questions about the sustainability and quality of earnings. Investors should treat the company’s forward-looking statements as aspirational until more granular, profit-based disclosures are provided. The most important takeaway is that while operational momentum is evident, the lack of full financial transparency limits conviction in the record-year outlook.

Announcement summary

(ASX: DEM) De.mem Limited generated $20 million in cash receipts during the first half and produced positive operating cash flow of $928,000 in the same period, compared with an outflow of about $1.9m in CY2022. Cash increased from $4m at the end of December 2025 to $4.3m at 30 June 2026, with more than 90% of receipts coming from recurring sources. The company acquired Core Chemicals in October 2025 for total consideration of $2.68m, with 85% payable in cash and 15% in De.mem shares through two milestone-linked tranches. Core Chemicals generated about $4m in revenue and $730,000 in pre-tax profit before acquisition and is tracking approximately 15% above its pre-acquisition revenue level. De.mem reports a compound annual growth rate of about 24% over seven years and has completed six earlier bolt-on acquisitions since 2019, with average revenue growth of about 70%. The company estimates its Australian addressable market at $2.3 billion and services 18 mines in Western Australia at average annual revenue of about $222,000 per customer. The company projects record results for CY2026 and is rolling out standardised domestic water filtration systems, with a new Singapore filter cartridge order worth about $100,000.

Disagree with this article?